| Product Code: ETC12835845 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Infectious Disease Drugs Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Infectious Disease Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 China Infectious Disease Drugs Market - Industry Life Cycle |
3.4 China Infectious Disease Drugs Market - Porter's Five Forces |
3.5 China Infectious Disease Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 China Infectious Disease Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 China Infectious Disease Drugs Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 China Infectious Disease Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 China Infectious Disease Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in China |
4.2.2 Rising awareness about the importance of early diagnosis and treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 High competition among pharmaceutical companies in the infectious disease drugs market |
4.3.3 Limited access to healthcare in rural areas of China |
5 China Infectious Disease Drugs Market Trends |
6 China Infectious Disease Drugs Market, By Types |
6.1 China Infectious Disease Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 China Infectious Disease Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 China Infectious Disease Drugs Market Revenues & Volume, By Antiviral, 2021 - 2031F |
6.1.4 China Infectious Disease Drugs Market Revenues & Volume, By Antibiotic, 2021 - 2031F |
6.1.5 China Infectious Disease Drugs Market Revenues & Volume, By Antifungal, 2021 - 2031F |
6.2 China Infectious Disease Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Infectious Disease Drugs Market Revenues & Volume, By Respiratory Infections, 2021 - 2031F |
6.2.3 China Infectious Disease Drugs Market Revenues & Volume, By Gastrointestinal Infections, 2021 - 2031F |
6.2.4 China Infectious Disease Drugs Market Revenues & Volume, By Bloodborne Infections, 2021 - 2031F |
6.3 China Infectious Disease Drugs Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 China Infectious Disease Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Infectious Disease Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 China Infectious Disease Drugs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 China Infectious Disease Drugs Market, By Mode of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Infectious Disease Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 China Infectious Disease Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
7 China Infectious Disease Drugs Market Import-Export Trade Statistics |
7.1 China Infectious Disease Drugs Market Export to Major Countries |
7.2 China Infectious Disease Drugs Market Imports from Major Countries |
8 China Infectious Disease Drugs Market Key Performance Indicators |
8.1 Percentage increase in government spending on healthcare infrastructure |
8.2 Number of new drug approvals for infectious diseases in China |
8.3 Percentage increase in healthcare coverage in rural areas |
9 China Infectious Disease Drugs Market - Opportunity Assessment |
9.1 China Infectious Disease Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 China Infectious Disease Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 China Infectious Disease Drugs Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 China Infectious Disease Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 China Infectious Disease Drugs Market - Competitive Landscape |
10.1 China Infectious Disease Drugs Market Revenue Share, By Companies, 2024 |
10.2 China Infectious Disease Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here